La Jolla, CA (PRWEB) October 25, 2012
WHAT: CHI is hosting CHI 2012, the annual meeting of biomedical executives and health policy experts, at the Gilead Sciences campus
WHO: Health and policy experts from Amgen, Avalere Health, CHI, California HealthCare Foundation, Chapman University, City of Hope, FasterCures, Gilead Sciences, Leerink Swann, OncoMed Pharmaceuticals, Orexigen Therapeutics, Sidley Austin LLP, Stanford University School of Medicine, Thermo Fisher, the California Legislature and the Governor’s Office of Business and Economic Development (GO-Biz).
WHY: This event brings together hundreds of representatives from CHI’s member organizations with policymakers to discuss critical issues and opportunities facing the biomedical community. The goal of the forum is to produce a clearer understanding of the biomedical community’s work and needs, and how the industry can sustain California’s leadership in medical innovation.
WHO SHOULD ATTEND: Leaders from California’s biomedical industry, academic research community, entrepreneurs, healthcare providers, investors, members of the media, policy experts and patient advocates.
WHEN: Thursday, Nov. 8
Networking Breakfast and Registration: 8-9 a.m.
Panel discussions and keynotes: 9:30 a.m.-5 p.m.
Lunch Keynote: 11:30 a.m.-1 p.m.
Networking Break: 2:30-3 p.m.
Reception: 5–6 p.m.
WHERE: Gilead Sciences
333 Lakeside Drive
Foster City, CA 94404
For more information, visit http://www.chi.org.
Media registration/Heather Chambers
Event registration/Marisa Reinoso
The California Healthcare Institute represents more than 275 leading biotechnology, medical device, diagnostics, and pharmaceutical companies, and public and private academic biomedical research organizations. CHI’s mission is to advance responsible public policies that foster medical innovation and promote scientific discovery. CHI’s website is chi.org. Follow us on Twitter @calhealthcare, Facebook, LinkedIn and YouTube.